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A B S T R A C T
Objective: A previous randomized clinical trial (RCT) compared immediate treatment with intrauterine
insemination (IUI) to expectant management for six months in subfertile couples with an isolated
cervical factor. That study showed higher ongoing pregnancy rates in couples receiving intrauterine
insemination. The current study compared the long-term effectiveness and costs of this intervention.
Study design: We followed all couples (N = 99) who were previously included in the RCT for three years
after randomization and registered pregnancies and treatments. After the initial trial period, couples in
both groups were offered further treatment according to local protocol. The primary outcome was an
ongoing pregnancy after three years.
Results: After three years, there were 36 ongoing pregnancies in the immediate IUI group (N = 51
couples) and 38 ongoing pregnancies in the expectant management group (N = 48 couples). The ongoing
pregnancy rates were 71% and 79% respectively (RR 0.89 (95% conﬁdence interval (CI) 0.7–1.1)).
Conclusions: In couples with an isolated cervical factor, a treatment strategy including immediate
treatment with IUI does not result in higher ongoing pregnancy rates on the long term. Initial expectant
management is therefore justiﬁed in these couples and identifying a cervical factor by a post-coital test is
unnecessary.
 2013 Elsevier Ireland Ltd. All rights reserved.
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Despite regular unprotected intercourse, 10% of couples with a
wish for a child fail to conceive within a year [1]. In 5% of these
couples the basic fertility work-up reveals a cervical factor, deﬁned
as an abnormal post coital test, despite normal semen quality [2].
Previously, we have assessed the effectiveness of immediate IUI
compared to expectant management for 6 months in couples with
a cervical factor and a good prognosis on natural conception. Six
months of IUI trended toward having better ongoing pregnancy
rates than expectant management (relative risk 1.6 (95% conﬁ-
dence interval (CI) 0.9–2.8)) [3]. Based on these data, IUI seems an
effective treatment option for subfertile couples with an isolated
cervical factor.
Nevertheless, the evidence underpinning immediate start of IUI
is not robust enough due to the lack of a statistically signiﬁcant
difference and the lack of long-term follow-up. We therefore* Corresponding author at: Centre for Reproductive Medicine, Academic Medical
Centre, Department of Obstetrics and Gynaecology, Meibergdreef 9, 1105 AZ
Amsterdam, The Netherlands. Tel.: +0031 6 42450402; fax: +0031 20 6963489.
E-mail address: I.Scholten@amc.uva.nl (I. Scholten).
0301-2115/$ – see front matter  2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejogrb.2013.06.042followed all couples included in the previously mentioned trial
until three years after randomization, to assess the long-term
effectiveness and costs of immediate start with IUI versus initial
expectant management for six months in couples with an isolated
cervical factor.
2. Materials and methods
2.1. Patients
Between June 2002 and July 2005 ninety-nine couples were
included in a randomized clinical trial performed in 17 fertility
centers in The Netherlands [3]. All couples with an unfulﬁlled wish
for a child for more than one year underwent a basic fertility work
up, according to the guidelines of the Dutch Society of Obstetrics
and Gynaecology [4,5]. At least one postcoital test was done for
each couple during the basic fertility assessment [5].
After completion of the basic fertility work-up the prognosis for
natural conception within one year was calculated. These
calculations were performed by an externally validated prediction
model for natural conception in the next year [6,7].
Couples with an isolated cervical factor, diagnosed by a well-
timed non-progressive postcoital test (PCT) [3] and a good
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deﬁned as the absence of spermatozoa moving in a straight
direction and at functional speed. The prognosis for natural
conception, without taking into account the result of the PCT, had
to be more than 30% within 12 months.
2.2. Procedures
Couples had been randomly allocated to immediate treatment
or expectant management for six months. Couples allocated to
immediate treatment started IUI in the next menstrual cycle. The
ﬁrst three cycles were performed without controlled ovarian
hyperstimulation (COH) [8]. Subsequent cycles were performed
with COH.
After the study period all couples were offered further
treatment according to local protocol. Couples who had
initially been allocated to immediate treatment but had not
conceived after completing six cycles of IUI usually continued
with IVF. Couples who had initially been allocated to expectant
management usually continued with six cycles of IUI followed
by IVF if necessary. IUI and IVF procedures were performed
according to local protocol. In most clinics, IUI was performed
with COH.
2.3. Follow up
Couples were followed for three years after randomization or
until an ongoing pregnancy occurred. Data were obtained from the
medical ﬁle or by contacting the couple.
The Institutional Review Board (IRB) of each participating
center approved the initial randomized trial. Written informed
consent was then obtained. The current study was exempt from
IRB approval. The Dutch Medical Research Involving Human
Subjects Act states that IRB approval is only required when
patients are subjected to an intervention, and thus was not
mandatory for this observational study using data collected during
standard care.
The primary outcome measure was ongoing pregnancy after
three years, deﬁned as the presence of fetal cardiac activity at
transvaginal sonography, at a gestational age of 12 weeks.
Secondary outcomes were treatment cycles, live birth, miscar-
riages, ectopic pregnancies, multiple pregnancies, pregnancy and
time to ongoing pregnancy. Miscarriage was deﬁned as non-viable
pregnancy, seen at transvaginal sonography or as the result of the
loss of a visible pregnancy. Ectopic pregnancy was deﬁned as a
pregnancy located outside the uterus that required medical or
surgical treatment. Pregnancy was deﬁned as an ongoing
pregnancy, miscarriage or ectopic pregnancy.
The number of natural IUI, IUI with COH and IVF cycles in both
groups was registered and ongoing pregnancy rates per cycle were
calculated.
2.4. Analysis
The analysis was performed according to the intention-to-treat
principle i.e. all pregnancies that occurred in the three years
following randomization were accounted for in the initial
randomized group, whether they occurred after natural concep-
tion, IUI or IVF. The treatment effect of immediate IUI was
expressed as a relative risk with a 95% CI. Chi-square test was used
to compare the usage of IUI of IVF. We plotted Kaplan–Meier curves
to visualize the differences in time to ongoing pregnancy between
the two groups, and compared these curves by using a log rank test.
In all analyses a P-value of 0.05 was used as to indicate statistical
signiﬁcance. Calculations were performed with SPSS1 (SPSS Inc.,
Chicago, IL).2.5. Economic analysis
An economic analysis alongside the trial was carried out from a
health care perspective. The ongoing pregnancy rates determined
whether a cost-minimization analysis or cost-effectiveness analy-
sis would be performed. We recorded the number of IUI and IVF
cycles and used assumptions concerning costs from an inventory
study of mean costs made in each treatment cycle in The
Netherlands [9,10]. We assumed that the costs for couples who
received no treatment were zero. The average total dose of
gonadotrophins (FSH) used for the ovarian hyperstimulation in IUI
was estimated and set at 800 units of FSH per cycle [9,10]. In the IUI
cycles without controlled ovarian hyperstimulation (COH), no
medication costs were taken into account. The average total dose
of gonadotrophins (FSH) used for the ovarian hyperstimulation in
IVF was estimated and set at 2000IU. We used a discount of 5% over
a period of three years, correcting for the fact that money spent or
saved is worth less than the same amount today [11,12]. The unit
costs for one cycle of IVF, one cycle of IUI-COH and one cycle of IUI
without COH were estimated at s 2139, s 773 and s 439,
respectively.
We calculated the mean costs for both strategies and the
difference of the mean with a 95% conﬁdence interval. The costs for
one ongoing pregnancy were calculated. The mean costs and the
conﬁdence boundaries were estimated by non-parametric boot-
strapping to account for both the uncertainty in the collected data
and the expected skewing of the data due to the relatively high
proportion of patients with no or very low costs [13].
To explore the effect of variations in FSH use and replacement
by clomiphene citrate, we calculated the costs for two scenarios,
one in which a high dose of 1000IU FSH was used and one in which
clomiphene citrate was used.
3. Results
In the initial study, 51 couples started IUI immediately and 48
couples were assigned to expectant management for six months.
Baseline characteristics at the time of randomization were
comparable between both groups, and have been published in
the original article [3]. Mean female age was 30 years, mean
duration of subfertility was 1.6 years and the mean prognosis on a
natural conception within a year were 37% and 39% in the
immediate treatment group and the expectant management group
respectively.
Within the initial six months, 22 couples (43%) had an ongoing
pregnancy in the immediate treatment group, and 13 couples
(27%) in the expectant management group. This resulted in a
relative risk of 1.6 (95% CI 0.91–2.8) [3]. Three couples with an
ongoing pregnancy after six months of follow-up had a
miscarriage beyond 12 weeks of pregnancy and were followed
further. This resulted in 6-months ongoing pregnancy rates
leading to live birth of 39% and 25% respectively (relative risk 1.6
(95% CI 0.83–3.1)). The remaining 67 couples were followed until
they achieved an ongoing pregnancy leading to live birth over a
period of three years (Fig. 1). Five couples in the immediate
treatment group and four couples in the expectant management
group were lost to follow-up before 3 years after randomization
(9%). These couples were included in the analysis until the last
moment of contact and no pregnancy in these couples had
occurred.
Overall, three years after inclusion, the number of ongoing
pregnancies was 36 (71%) in the immediate treatment group and
38 (79%) in the expectant management group, resulting in a
relative risk of 0.89 (95% CI 0.71–1.15) (Fig. 1). Kaplan–Meier
analysis indicated that time to ongoing pregnancy was comparable
in both groups. (Log rank test p = 0.91) (Fig. 2).
99 couples with isolated cervical factor
51 assigned to immediate treatment
with IUI
48 assigned to expectant
management
20 live births (39%) 12 live births (25%)
31 not pregnant 36 not pregnant
2 IVF
N= 6 cycles
23 IUI
N= 72 cycles6 no treatment
0 IVF 33 IUI
N= 167 cycles 3 no treatment
3
natural concepted
pregnancies
3 ongoing
pregnancies
after IUI
3 natural
concepted
pregnancies
1 ongoing
pregnancies
after IVF
no natural
concepted
pregnancies
14 ongoing
pregnancies
after IUI
4 natural
concepted
pregnancies
1
natural concepted
pregnancy
13 IVF
N= 34 cycles
10 IVF
N= 22 cycles
6 ongoing
pregnancies
after IVF
no natural
concepted
pregnancies
6 ongoing
pregnancies
after IVF
1 natural
concepted
pregnancy
36 ongoing pregnancies (71%) 38 ongoing pregnancies (79%)
Live birth N= 35
No ongoing pregnancy N= 12
Lost to follow up N= 5
Live birth N= 37
No ongoing pregnancy N= 7
Lost to follow up N= 4
6
months
30
months
Total
after 36
months
RR: 1.6
95% CI: 0.93-3.0
RR: 0.89
95% CI: 0.71-1.1
Fig. 1. Flowchart of treatment and pregnancy outcome over 3 years. RR = relative risk; CI = conﬁdence interval.
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initial trial ended are shown in Fig. 1. After three years, the total
number of pregnancies was 47 in the immediate treatment group
and 51 in the expectant management group. The miscarriages,
ectopic pregnancies and multiple pregnancies in both groups with
their relative risks are summarized in Table 1.
In the group initially allocated to immediate treatment, 219 IUI
cycles leading to insemination were performed: 122 cycles were
without COH, resulting in 10 ongoing pregnancies (8.2% per
performed cycle) and 90 were with COH, resulting in eight ongoing
pregnancies (8.9% per performed cycle). In seven cycles it was
unknown whether or not COH was applied: one of these cycles
resulted in an ongoing pregnancy. In addition, 40 IVF cycles were
started, resulting in seven ongoing pregnancies (25.9% per started
IVF cycle). Ten ongoing pregnancies occurred after natural
conception (Table 2).In the group initially allocated to expectant management 156
IUI cycles leading to insemination were performed: 59 cycles were
without stimulation, resulting in three ongoing pregnancies (5.1%
per performed cycle) and 91 cycles were with COH, resulting in 12
ongoing pregnancies (13.2% per performed cycle). From six cycles
it was unknown whether or not COH was applied. Furthermore, 22
IVF cycles were started, resulting in six ongoing pregnancies (33.3%
per started IVF cycle). Seventeen ongoing pregnancies occurred
after natural conception (Table 2).
The number of IUI and IVF cycles was comparable between the
two groups, p = 0.09 and p = 0.29, respectively.
3.1. Economic analysis
The economic analysis was performed on 91 of 99 included
couples, 47 in the immediate treatment group and 44 in the
Fig. 2. Time to ongoing pregnancy in couples initially randomized between
immediate treatment and expectant management.
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excluded from the economic analysis because data on the
treatment cycles they received was not complete.
Given the comparable ongoing pregnancy rates, we performed a
cost-minimization analysis. In the immediate treatment group the
total costs were s 194,158, versus s 149,752 in the expectant
management group, resulting in mean costs per couple of s 4131Table 1
Pregnancy outcome after three years.
Immediate
treatment
(N = 51)
Expectant
management
(N = 48)
RR (95% CI)
All pregnancies 47 51
Ongoing pregnancies n (%) 36 (71) 38 (80) 0.89 (0.71–1.1)
Miscarriages n (%) 10 (20) 12 (25) 0.78 (0.34–1.8)
Ectopic pregnancies n (%) 1 (2) 1 (2) 0.94 (0.026–34)
Twin pregnancies n (%) 3 (6) 5 (10) 0.57 (0.11–2.6)
Note. RR = relative risk, CI = conﬁdence interval.
Table 2
Ongoing pregnancies per group and per treatment cycle (IUI and IVF).
Immediate
treatment
(N = 51)
Expectant
management
(N = 48)
RR (95% CI)
Natural concepted ongoing
pregnancies, n (%)
10 (20) 18 (38) 0.52 (0.25–1.1)
Number of IUI cyclesa 219 156
Ongoing pregnancies
after IUI, n (%)
19 (37) 14 (29) 1.3 (0.69–2.4)
% Ongoing pregnancy
per IUI cycle
8.7 9.0 0.91 (0.35–2.3)
Number of IVF cyclesb 40 22
Ongoing pregnancies
after IVF, n (%)
7 (14) 6 (13) 1.1 (0.35–3.5)
% Ongoing pregnancy
per IVF cycle
18 27 0.63 (0.39–1.0)
Note. RR = relative risk, CI = conﬁdence interval.
a Mann–Whitney U test to compare number of cycles p = 0.09.
b Mann–Whitney U test to compare number of cycles p = 0.29.(95% CI s 3070 to s 5273) and s 3403 (95% CI s 2344–4597,
respectively. This resulted in an estimated saving of s 728 (95% CI
s 1010 to 2436) per couple after applying expectant manage-
ment. The estimated costs expressed per ongoing pregnancy were
s 5393 for pregnancies in the immediate treatment group and s
3941 for pregnancies in the expectant management group.
To explore the effect of plausible variations in ovarian
stimulation protocols, sensitivity analyses were performed.
Neither using clomiphene citrate (CC) instead of gonadotrophins
nor using a higher dose of gonadotrophins resulted in a change of
preferred treatment in terms of cost-effectiveness.
4. Comments
We compared the long-term consequences of immediate
treatment with IUI and delayed treatment with initial expectant
management for six months in couples with an isolated cervical
factor. In contrast to the results after six months, three years after
randomization the cumulative ongoing pregnancy rate and the
time to pregnancy were comparable for both treatment groups.
Initial expectant management followed by IUI and IVF in the case
of no pregnancy resulted in an average potential saving of almost s
1000 per couple.
The strengths of this study are, ﬁrstly, that we followed a strict
treatment protocol with intention-to-treat analysis. Owing to the
long period of follow up (3 years), couples were able to complete
six cycles of IUI-COS followed by three cycles of IVF, if necessary.
We therefore feel that this study reﬂects daily practice and the
results should be applicable to all couples with isolated cervical
factor subfertility and a good prognosis of natural conception.
Secondly, we reckon our outcomes on costs are transferable to
other countries although the calculated costs were based on health
care costs in The Netherlands. All items, except the costs of side-
effects (multiple pregnancies), of the guideline of EURONHEED
[15] were implemented and trend should thus be transferable.
A limitation of this study is the retrospective collection of our
data. Due to this, some couples were lost to follow up. Since these
couples were equally distributed to both randomization groups,
the loss of data probably does not affect the outcome.
Our long-term pregnancy rates are conﬁrmed by a recently
published longitudinal cohort study that reports a long-term
ongoing pregnancy rate for couples with cervical factor of 80%
compared to 75% in our study [16]. Of the couples with cervical
factor in this cohort 38.7% conceived naturally, conﬁrming the
good chance of spontaneous pregnancy for these couples and
therefore justifying expectant management.
We are aware that the PCT has been abandoned in many
guidelines. Couples with a cervical factor are then not identiﬁed.
Consequently, these couples will be treated as unexplained
subfertile couples and therefore receive expectant management
or IUI with COH, depending their prognosis on natural conception
[17]. Our long-term results provide the scientiﬁc basis for this
strategy [5,18]. Furthermore, we found that starting treatment
immediately increased the costs by s 728 per couple, although this
difference was not statistically signiﬁcant. The underlying cost
drivers, however, i.e. the number of cycles IUI and IVF, were
signiﬁcantly increased in the immediate treatment group, making
this difference likely to be a true difference.
In conclusion, in couples with cervical factor subfertility and an
otherwise good prognostic proﬁle, an immediate start of treatment
with IUI results in somewhat higher pregnancy rates on the short
term, but the overall costs are increased for no beneﬁt in terms of
three-year pregnancy rates. In these couples, initial expectant
management treatment is thus justiﬁed and identiﬁcation of a
cervical factor is not necessary.
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